Page last updated: 2024-09-04

4-(2-succinimidyloxycarbonylethyl)phenyl-10-methylacridinium-9-carboxylate and Granulocytic Leukemia, Chronic

4-(2-succinimidyloxycarbonylethyl)phenyl-10-methylacridinium-9-carboxylate has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cook, RW; Gale, RE; Harvey, RC; Langabeer, SE; Linch, DC; Mackinnon, S1

Other Studies

1 other study(ies) available for 4-(2-succinimidyloxycarbonylethyl)phenyl-10-methylacridinium-9-carboxylate and Granulocytic Leukemia, Chronic

ArticleYear
Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia.
    Leukemia, 2002, Volume: 16, Issue:3

    Topics: Acridines; Bone Marrow Transplantation; DNA Probes; Fusion Proteins, bcr-abl; Gene Amplification; Graft Enhancement, Immunologic; Humans; Hybridization, Genetic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luminescent Measurements; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Risk Factors; RNA, Messenger; RNA, Neoplasm; Succinimides; Transcription, Genetic

2002